Skip to main content
Dan Longo, MD, Oncology, Brookline, MA, Brigham and Women's Hospital

DanL.LongoMD

Oncology Brookline, MA

Professor of Medicine, Brigham and Women's Hospital

Dr. Longo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Longo's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1975 - 1977
  • University of Missouri-Columbia School of Medicine
    University of Missouri-Columbia School of MedicineClass of 1975

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1976 - 2025
  • MD State Medical License
    MD State Medical License 1977 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • SARS-CoV-2 Vaccination — an Ounce (Actually, Much Less) of Prevention  
    Eric J Rubin, Dan L Longo, The New England Journal of Medicine
  • Paradoxical Effects of Obesity on T Cell Function During Tumor Progression and PD-1 Checkpoint Blockade  
    R Rivkah Isseroff, Emanual Maverakis, Robert J Canter, Kurt A Schalper, Karen Kelly, Bruce R Blazar, Catherine T Le, Dan L Longo, Arta M Monjazeb, Sami Ibrahimi, Nature
  • Plateletpheresis-Associated Lymphopenia in Frequent Platelet Donors  
    Michael B Brenner, John M Gansner, A Helena Jonsson, Dan L Longo, Jason M Schenkel, Deepak A Rao, Richard M Kaufman, Nancy Berliner, Duane R Wesemann, Blood

Abstracts/Posters

  • Macrophage Checkpoint Blockade in Cancer — Back to the Future
    Dan Longo, MD, The New England Journal of Medicine, Orlando, FL, 12/8/2019

Press Mentions

  • CAR T-cell Therapy Feasible, Safe in Advanced Neuroblastoma
    CAR T-cell Therapy Feasible, Safe in Advanced NeuroblastomaApril 6th, 2023
  • CAR T-cell Win Streak Stopped by Negative Trial in Aggressive LBCL
    CAR T-cell Win Streak Stopped by Negative Trial in Aggressive LBCLDecember 14th, 2021
  • Covid-19: Vets Study Finds mRNA-1273 Covid Vaccine Slightly More Effective Than BNT162b2
    Covid-19: Vets Study Finds mRNA-1273 Covid Vaccine Slightly More Effective Than BNT162b2December 2nd, 2021
  • Join now to see all

Grant Support

  • The Reveal StudyNational Institute On Aging2009
  • Structure-Function Relationship Of NFKB P65National Institute On Aging2009
  • Shaping The Preimmune B Cell RepertoireNational Institute On Aging2009
  • Role Of Hyperplasia Suppressor Gene (HSG) In Cell Growth.National Institute On Aging2009
  • Rapamycin-Sensitive Pathway Of T Cell ActivationNational Institute On Aging2009
  • Long-Term Consequences Of Lymphoma And Its TreatmentNational Institute On Aging2009
  • Cytapheresis Of Volunteer Donors (Mri 2003-054)National Institute On Aging2009
  • Characterization Of Tgf-B Signaling In A B-Cell Lymphoma Cell LINENational Institute On Aging2009
  • Acute Leukemia In The Elderly: Development Of Novel, Targeted TherapeuticsNational Institute On Aging2009
  • Acute Leukemia In The Elderly: Development Of Novel, Targeted TherapeuticsNational Institute On Aging2008
  • Characterization Of Tgf-B Signaling In A B-Cell Lymphoma Cell LINENational Institute On Aging2007–2008
  • Structure-Function Relationship Of NFKB P65National Institute On Aging2005–2008
  • Rapamycin-Sensitive Pathway Of T Cell ActivationNational Institute On Aging2005–2008
  • Shaping The Preimmune B Cell RepertoireNational Institute On Aging2002–2008
  • Tumor-Induced ImmunosuppressionNational Institute On Aging2002–2007
  • Cell Biology Of LymphomaNational Institute On Aging2000–2007
  • Characterization Of Tgf-B Signaling In A B-Cell LymphomaNational Institute On Aging2006
  • Characterization Of Tgf-B Signaling In B-Cell LymphomaNational Institute On Aging2005
  • Role Of SMAD3 In Tgf-B Signaling In A B-Cell Lymphoma CENational Institute On Aging2004
  • Role Of PTEN In T Cell ActivationNational Institute On Aging2002–2004
  • Cyclosporin A-Resistant Co-Stimulation VIA CD28National Institute On Aging2002–2004
  • Regulation Of Mutant P53National Institute On Aging2000–2004
  • SMAD3 In Tgf-B Signaling In B Cell Lymphoma Cell LINENational Institute On Aging2003
  • SMAD3 In Tgf-B Signaling In A B-Cell Lymphoma Cell LINENational Institute On Aging2002
  • Regulation Of Interferon-Gamma Gene In Freshly DifferentNational Institute On Aging2002
  • Regulation Of Interferon-Gamma Gene In TH1 And TH2 CellsNational Institute On Aging2001
  • Cyclosporin A Resistant Costimulation VIA CD28National Institute On Aging2001
  • Tumor Induced ImmunosuppressionNational Institute On Aging2000–2001
  • Role Of Cadherins In Tumor ProgressionNational Institute On Aging2000–2001
  • Role Of SAP In Lymphocyte Sub PopulationsNational Institute On Aging2000
  • Cyclosporin A Resistant CO Stimulation VIA CD28National Institute On Aging2000
  • Host Tumor InteractionsNational Institute On Aging1999

Professional Memberships

Hospital Affiliations